First Time Loading...

Biodesix Inc
NASDAQ:BDSX

Watchlist Manager
Biodesix Inc Logo
Biodesix Inc
NASDAQ:BDSX
Watchlist
Price: 1.26 USD -1.56% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

BDSX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. [ Read More ]

The intrinsic value of one BDSX stock under the Base Case scenario is 3.06 USD. Compared to the current market price of 1.26 USD, Biodesix Inc is Undervalued by 59%.

Key Points:
BDSX Intrinsic Value
Base Case
3.06 USD
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biodesix Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BDSX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biodesix Inc

Provide an overview of the primary business activities
of Biodesix Inc.

What unique competitive advantages
does Biodesix Inc hold over its rivals?

What risks and challenges
does Biodesix Inc face in the near future?

Has there been any significant insider trading activity
in Biodesix Inc recently?

Summarize the latest earnings call
of Biodesix Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biodesix Inc.

Provide P/S
for Biodesix Inc.

Provide P/E
for Biodesix Inc.

Provide P/OCF
for Biodesix Inc.

Provide P/FCFE
for Biodesix Inc.

Provide P/B
for Biodesix Inc.

Provide EV/S
for Biodesix Inc.

Provide EV/GP
for Biodesix Inc.

Provide EV/EBITDA
for Biodesix Inc.

Provide EV/EBIT
for Biodesix Inc.

Provide EV/OCF
for Biodesix Inc.

Provide EV/FCFF
for Biodesix Inc.

Provide EV/IC
for Biodesix Inc.

Show me price targets
for Biodesix Inc made by professional analysts.

What are the Revenue projections
for Biodesix Inc?

How accurate were the past Revenue estimates
for Biodesix Inc?

What are the Net Income projections
for Biodesix Inc?

How accurate were the past Net Income estimates
for Biodesix Inc?

What are the EPS projections
for Biodesix Inc?

How accurate were the past EPS estimates
for Biodesix Inc?

What are the EBIT projections
for Biodesix Inc?

How accurate were the past EBIT estimates
for Biodesix Inc?

Compare the revenue forecasts
for Biodesix Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biodesix Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biodesix Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biodesix Inc compared to its peers.

Compare the P/E ratios
of Biodesix Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Biodesix Inc with its peers.

Analyze the financial leverage
of Biodesix Inc compared to its main competitors.

Show all profitability ratios
for Biodesix Inc.

Provide ROE
for Biodesix Inc.

Provide ROA
for Biodesix Inc.

Provide ROIC
for Biodesix Inc.

Provide ROCE
for Biodesix Inc.

Provide Gross Margin
for Biodesix Inc.

Provide Operating Margin
for Biodesix Inc.

Provide Net Margin
for Biodesix Inc.

Provide FCF Margin
for Biodesix Inc.

Show all solvency ratios
for Biodesix Inc.

Provide D/E Ratio
for Biodesix Inc.

Provide D/A Ratio
for Biodesix Inc.

Provide Interest Coverage Ratio
for Biodesix Inc.

Provide Altman Z-Score Ratio
for Biodesix Inc.

Provide Quick Ratio
for Biodesix Inc.

Provide Current Ratio
for Biodesix Inc.

Provide Cash Ratio
for Biodesix Inc.

What is the historical Revenue growth
over the last 5 years for Biodesix Inc?

What is the historical Net Income growth
over the last 5 years for Biodesix Inc?

What is the current Free Cash Flow
of Biodesix Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biodesix Inc.

Financials

Balance Sheet Decomposition
Biodesix Inc

Current Assets 39.7m
Cash & Short-Term Investments 26.3m
Receivables 7.7m
Other Current Assets 5.7m
Non-Current Assets 59.4m
PP&E 29.6m
Intangibles 22.9m
Other Non-Current Assets 6.9m
Current Liabilities 33.4m
Accounts Payable 2.9m
Accrued Liabilities 5.1m
Other Current Liabilities 25.4m
Non-Current Liabilities 61.1m
Long-Term Debt 35.2m
Other Non-Current Liabilities 25.9m
Efficiency

Earnings Waterfall
Biodesix Inc

Revenue
49.1m USD
Cost of Revenue
-13m USD
Gross Profit
36.1m USD
Operating Expenses
-77.4m USD
Operating Income
-41.3m USD
Other Expenses
-10.8m USD
Net Income
-52.1m USD

Free Cash Flow Analysis
Biodesix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BDSX Profitability Score
Profitability Due Diligence

Biodesix Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Operating Income
26/100
Profitability
Score

Biodesix Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

BDSX Solvency Score
Solvency Due Diligence

Biodesix Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Short-Term Solvency
Long-Term Solvency
High D/E
23/100
Solvency
Score

Biodesix Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BDSX Price Targets Summary
Biodesix Inc

Wall Street analysts forecast BDSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BDSX is 3.57 USD with a low forecast of 3.54 USD and a high forecast of 3.68 USD.

Lowest
Price Target
3.54 USD
181% Upside
Average
Price Target
3.57 USD
183% Upside
Highest
Price Target
3.68 USD
192% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BDSX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BDSX Price
Biodesix Inc

1M 1M
-13%
6M 6M
-17%
1Y 1Y
-21%
3Y 3Y
-93%
5Y 5Y
-90%
10Y 10Y
-90%
Annual Price Range
1.26
52w Low
1.04
52w High
2.13
Price Metrics
Average Annual Return -26.94%
Standard Deviation of Annual Returns 70.65%
Max Drawdown -97%
Shares Statistics
Market Capitalization 144.1m USD
Shares Outstanding 114 334 000
Percentage of Shares Shorted 0.57%

BDSX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biodesix Inc Logo
Biodesix Inc

Country

United States of America

Industry

Health Care

Market Cap

144.1m USD

Dividend Yield

0%

Description

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 218 full-time employees. The company went IPO on 2020-10-28. The firm uses its artificial intelligence (AI) platform, Diagnostic Cortex, to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus on lung disease. In addition to its diagnostic tests, it provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development and commercialization of companion diagnostics. The firm offers blood-based lung cancer tests across the lung cancer continuum of care, including Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. The firm also offers three SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralization Antibody Test.

Contact

COLORADO
Boulder
2970 Wilderness Place, Suite 100
+13034170500.0
https://www.biodesix.com/

IPO

2020-10-28

Employees

218

Officers

President, CEO & Director
Mr. Scott Hutton
CFO, Secretary & Treasurer
Ms. Robin Harper Cowie
Founder & CTO
Dr. Heinrich Röder
VP, Controller & Chief Accounting Officer
Mr. Christopher Vazquez
Vice President of Sales
Mr. Mark DeBlock
Senior Director of Marketing
Mr. Robbie Lunt
Show More
Senior Director of Human Resources
Ms. Jessica Olbricht
Chief Development Officer
Dr. Gary Anthony Pestano Ph.D.
Chief Growth Officer
Ms. Bobbi Coffin
Co-Chief Medical Officer
Dr. James R. Jett M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BDSX stock?

The intrinsic value of one BDSX stock under the Base Case scenario is 3.06 USD.

Is BDSX stock undervalued or overvalued?

Compared to the current market price of 1.26 USD, Biodesix Inc is Undervalued by 59%.